Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Clinical trial NCT01392989 · COMPLETED

Trial details

NCT number: NCT01392989
Sponsor: Everett Meyer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neural Tube Defects Anemia Leukemia, Myeloid Bone Marrow Transplant Failure Myelodysplastic Syndromes (MDS)Myeloproliferative Disorders

Start date: 2011-03-01
Primary completion: 2016-06-07
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.